Laser photocoagulation for diabetic retinopathy

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 8, 2014, Pages

  Evans, Jennifer R ^a   Fau, Christian ^b   Virgili, Gianni ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Research Fundación 2020   (Chile)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEST CORRECTED VISUAL ACUITY; CLINICAL EFFECTIVENESS; DIABETIC RETINOPATHY; HUMAN; LASER COAGULATION; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA DETACHMENT; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

EID: 85041712425     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011234     Document Type: Article

References (18)

1. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
2. Davidson JA, Ciulla TA, McGill JB, Kles KA, Anderson PW. How the diabetic eye loses vision. Endocrine 2007;32(1):107-16.
3. Anonymous. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5. Developments in Ophthalmology 1981;2:248-61.
4. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
5. Grover D, Li T, Chong CC. Intravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: ]
6. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al.GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94.
7. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
8. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
9. Jorge EC, Jorge EN, El Dib R. Laser photocoagulation for diabetic macular oedema. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: ]
10. Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Pijoán JI, Buil-Calvo JA. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: ]
11. Ockrim Z, Yorston D. Managing diabetic retinopathy. BMJ 2010;341:c5400.
12. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. British Journal of Ophthalmology 2012;96(5):614-8.
13. Royal College of Ophthalmologists. Diabetic Retinopathy Guidelines 2012. www.rcophth.ac.uk/page.asp?section=451 (accessed 14 March 2014).
14. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
15. Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmologica Scandinavica 2001;79(5):435-40.
16. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
17. Virgili G, Parravano M, Menchini F, Brunetti M. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: ]
18. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.